NCT00374699View on ClinicalTrials.gov

Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

55

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

September 30, 2009

Study Completion Date

October 31, 2009

Conditions

Peripheral T-Cell LymphomasNon-Hodgkin Lymphoma

Interventions

DRUG

Velcade

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

Sponsors

Collaborators (1)

Janssen Medical Affairs

All Listed Sponsors

collaborator

Janssen Medical Affairs

INDUSTRY

lead

Samsung Medical Center

OTHER